NCT05742204Active, not recruiting
Plasma Proteomic Biomarkers for Early Diagnosis of Lung Cancer
Identification and Functional Verification Study in Plasma Proteomic Biomarkers for Early Diagnosis of Lung Cancer
Source: ClinicalTrials.gov · Last updated 30 Sept 2026
Brief summary (registry, in English)
We will identify plasma proteomics biomarkers for early diagnosis of lung cancer.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 3700 (estimated)
- First submitted
- 15 Feb 2023
- Start date
- 1 Feb 2023
- Primary completion date
- 1 May 2025
- Lead sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Diseases
- Lung cancer
- NCT number
- NCT05742204
What you commit to
- Study type: Observational
- Planned participants: 3700
- From 1 Feb 2023 to the primary completion date, 1 May 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Received any treatment related to pulmonary nodules, such as antibiotics and hormones, in the past 4 weeks
Other illness
- There is a history of tumor
- Clinically uncontrolled active infections, such as acute pneumonia, tuberculosis, etc.
- Complicated with other tumors and serious diseases of the heart, liver, kidney, brain, blood and other systems
- Combined with liver and kidney insufficiency, hypoproteinemia and other diseases affecting protein content
Other
- Participated in other clinical trials within the last 3 months
- You are pregnant or breastfeeding
Who the study is looking for
- CT screening results showed that the size of pulmonary nodules was more than 5mm
- No treatment related to pulmonary nodules/lung cancer (including surgery, chemotherapy, radiotherapy, targeted therapy, immunotherapy, interventional therapy, etc.)
- Complete clinical and imaging data
- Chest CT/ low-dose spiral CT reports can be provided in the last 3 months
- Voluntarily sign informed consent
Age in the registry: 18 years to 80 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| 2nd Affiliated Hospital, School of Medicine, Zhejiang University Coordinator of this site? Confirm its status | Hangzhou | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.